H.P. Graversen

836 total citations
19 papers, 671 citations indexed

About

H.P. Graversen is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, H.P. Graversen has authored 19 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in H.P. Graversen's work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (8 papers) and Cancer and Skin Lesions (5 papers). H.P. Graversen is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (8 papers) and Cancer and Skin Lesions (5 papers). H.P. Graversen collaborates with scholars based in Denmark, Sweden and Norway. H.P. Graversen's co-authors include Johan A. Andersen, M Blichert-Toft, Karin Zedeler, Gyda Lolk Ottesen, M Blichert-Toft, I. J. Christensen, U Dyreborg, Anne Helene Olsen, C. K. Axelsson and Martin Bak and has published in prestigious journals such as The American Journal of Surgical Pathology, European Journal of Cancer and Breast Cancer Research and Treatment.

In The Last Decade

H.P. Graversen

19 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.P. Graversen Denmark 11 476 421 261 180 103 19 671
Gabriel Farante Italy 10 506 1.1× 332 0.8× 236 0.9× 175 1.0× 79 0.8× 23 683
Kathryn A Carolin United States 10 308 0.6× 219 0.5× 297 1.1× 108 0.6× 76 0.7× 11 586
M.H. Galea United Kingdom 11 218 0.5× 216 0.5× 166 0.6× 112 0.6× 140 1.4× 22 443
Malcolm Beinfield United States 11 683 1.4× 505 1.2× 274 1.0× 265 1.5× 35 0.3× 14 765
M. Del Vecchio Italy 6 545 1.1× 340 0.8× 271 1.0× 237 1.3× 27 0.3× 12 713
Amy Cyr United States 16 420 0.9× 281 0.7× 178 0.7× 246 1.4× 44 0.4× 46 607
Zoltán Mátrai Hungary 13 547 1.1× 391 0.9× 226 0.9× 392 2.2× 49 0.5× 75 756
Melissa Pilewskie United States 18 761 1.6× 532 1.3× 385 1.5× 254 1.4× 73 0.7× 54 1.0k
Cristina Olcese United States 11 316 0.7× 236 0.6× 148 0.6× 123 0.7× 38 0.4× 17 437
Kong Wee Ong Singapore 14 197 0.4× 220 0.5× 220 0.8× 138 0.8× 75 0.7× 26 442

Countries citing papers authored by H.P. Graversen

Since Specialization
Citations

This map shows the geographic impact of H.P. Graversen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.P. Graversen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.P. Graversen more than expected).

Fields of papers citing papers by H.P. Graversen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.P. Graversen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.P. Graversen. The network helps show where H.P. Graversen may publish in the future.

Co-authorship network of co-authors of H.P. Graversen

This figure shows the co-authorship network connecting the top 25 collaborators of H.P. Graversen. A scholar is included among the top collaborators of H.P. Graversen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.P. Graversen. H.P. Graversen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Njor, Sisse Helle, Anne Helene Olsen, U Dyreborg, et al.. (2003). Mammography screening in the county of Fyn. November 1993-December 1999.. PubMed. 1–33. 37 indexed citations
2.
Ottesen, Gyda Lolk, H.P. Graversen, M Blichert-Toft, I. J. Christensen, & Johan A. Andersen. (2000). Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Research and Treatment. 62(3). 197–210. 78 indexed citations
3.
4.
Grabau, D., Maj‐Britt Jensen, M Blichert-Toft, et al.. (1998). The importance of surgery and accurate axillary staging for survival in breast cancer. European Journal of Surgical Oncology. 24(6). 499–507. 16 indexed citations
5.
Graversen, H.P., et al.. (1997). A comparative study of post-operative psychosocial function in women with primary operable breast cancer randomized to breast conservation therapy or mastectomy. European Journal of Surgical Oncology. 23(4). 327–334. 69 indexed citations
6.
Teixeira, Manuel R., Nikos Pandis, Anne‐Marie Gerdes, et al.. (1996). Cytogenetic abnormalities in anin situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer. Breast Cancer Research and Treatment. 38(2). 177–182. 25 indexed citations
7.
Cataliotti, Luigi, Ian S. Fentiman, Emiel J. Rutgers, et al.. (1996). Comparison of the surgical procedures for breast conserving treatment of early breast cancer in seven EORTC centres. European Journal of Cancer. 32(11). 1866–1875. 25 indexed citations
8.
Date, John, Ulla Feldt‐Rasmussen, M Blichert-Toft, L Hegedüs, & H.P. Graversen. (1996). Long‐Term Observation of Serum Thyroglobulin after Resection of Nontoxic Goiter and Relation to Ultrasonographically Demonstrated Relapse. World Journal of Surgery. 20(3). 351–357. 10 indexed citations
9.
Teixeira, Manuel R., Nikos Pandis, Anne‐Marie Gerdes, et al.. (1995). Cytogenetic abnormalities in an in situ ductal carcinoma and five prophylactically removed breasts from members of a family with hereditary breast cancer. Cancer Genetics and Cytogenetics. 84(2). 156–156. 1 indexed citations
10.
11.
Petersen, Lone Kjeld, H.P. Graversen, Johan A. Andersen, U Dyreborg, & M Blichert-Toft. (1993). [The duct ectasia syndrome--an overlooked disease entity].. PubMed. 155(20). 1540–5. 3 indexed citations
12.
Petersen, Lone Kjeld, H.P. Graversen, Johan A. Andersen, U Dyreborg, & M Blichert-Toft. (1993). [The duct ectasia syndrome. A prospective clinical study of patients with breast diseases].. PubMed. 155(20). 1545–9. 3 indexed citations
13.
Ottesen, Gyda Lolk, H.P. Graversen, M Blichert-Toft, Karin Zedeler, & Johan A. Andersen. (1993). Lobular Carcinoma In Situ of the Female Breast. The American Journal of Surgical Pathology. 17(1). 14–21. 107 indexed citations
14.
Ottesen, Gyda Lolk, H.P. Graversen, M Blichert-Toft, Karin Zedeler, & Johan A. Andersen. (1992). Ductal Carcinoma In Situ of the Female Breast. The American Journal of Surgical Pathology. 16(12). 1183–1196. 128 indexed citations
15.
Graversen, H.P., M Blichert-Toft, U Dyreborg, & Johan A. Andersen. (1988). In Situ Carcinomas of the Female Breast Incidence, clinical findings and DBCG proposals for management. Acta Oncologica. 27(6). 679–682. 11 indexed citations
16.
Graversen, H.P., et al.. (1988). Cefoxitin for one day vs. ampicillin and metronidazole for three days in elective colorectal surgery. Diseases of the Colon & Rectum. 31(10). 774–777. 4 indexed citations
17.
Graversen, H.P., M Blichert-Toft, Johan A. Andersen, & Karin Zedeler. (1988). Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla.. PubMed. 14(5). 407–12. 124 indexed citations
18.
Blichert-Toft, M, H.P. Graversen, Johan A. Andersen, U Dyreborg, & Anders Green. (1988). In situ breast carcinomas: A population‐based study on frequency, growth pattern, and clinical aspects. World Journal of Surgery. 12(6). 845–850. 13 indexed citations
19.
Graversen, H.P., et al.. (1987). Uretero-pelvic stenosis. International Urology and Nephrology. 19(3). 245–251. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel Farante Breakdown of academic impact, for papers by Kathryn A Carolin Breakdown of academic impact, for papers by M.H. Galea Breakdown of academic impact, for papers by Malcolm Beinfield Breakdown of academic impact, for papers by M. Del Vecchio Breakdown of academic impact, for papers by Amy Cyr Breakdown of academic impact, for papers by Zoltán Mátrai Breakdown of academic impact, for papers by Melissa Pilewskie Breakdown of academic impact, for papers by Cristina Olcese Breakdown of academic impact, for papers by Kong Wee Ong
Rankless by CCL
2026